nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—Methocarbamol—Felbamate—epilepsy syndrome	0.51	1	CrCrCtD
Oxprenolol—CYP2D6—epilepsy syndrome	0.243	1	CbGaD
Oxprenolol—Sweating increased—Gabapentin—epilepsy syndrome	0.000309	0.00191	CcSEcCtD
Oxprenolol—Diplopia—Topiramate—epilepsy syndrome	0.000308	0.00191	CcSEcCtD
Oxprenolol—Fatigue—Midazolam—epilepsy syndrome	0.000308	0.0019	CcSEcCtD
Oxprenolol—Insomnia—Fosphenytoin—epilepsy syndrome	0.000308	0.0019	CcSEcCtD
Oxprenolol—Arthralgia—Oxcarbazepine—epilepsy syndrome	0.000308	0.0019	CcSEcCtD
Oxprenolol—Hyperhidrosis—Felbamate—epilepsy syndrome	0.000306	0.00189	CcSEcCtD
Oxprenolol—Hypotension—Diazepam—epilepsy syndrome	0.000305	0.00189	CcSEcCtD
Oxprenolol—Fatigue—Levetiracetam—epilepsy syndrome	0.000304	0.00188	CcSEcCtD
Oxprenolol—Headache—Rufinamide—epilepsy syndrome	0.000303	0.00187	CcSEcCtD
Oxprenolol—Thrombocytopenia—Zonisamide—epilepsy syndrome	0.000303	0.00187	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Vigabatrin—epilepsy syndrome	0.000302	0.00187	CcSEcCtD
Oxprenolol—Diarrhoea—Clobazam—epilepsy syndrome	0.000302	0.00187	CcSEcCtD
Oxprenolol—Psychotic disorder—Topiramate—epilepsy syndrome	0.000301	0.00186	CcSEcCtD
Oxprenolol—Dizziness—Lacosamide—epilepsy syndrome	0.000301	0.00186	CcSEcCtD
Oxprenolol—Insomnia—Vigabatrin—epilepsy syndrome	0.0003	0.00186	CcSEcCtD
Oxprenolol—Dyspepsia—Fosphenytoin—epilepsy syndrome	0.0003	0.00185	CcSEcCtD
Oxprenolol—Hyperhidrosis—Zonisamide—epilepsy syndrome	0.000299	0.00185	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Diazepam—epilepsy syndrome	0.000298	0.00184	CcSEcCtD
Oxprenolol—Palpitations—Lamotrigine—epilepsy syndrome	0.000296	0.00183	CcSEcCtD
Oxprenolol—Insomnia—Diazepam—epilepsy syndrome	0.000296	0.00183	CcSEcCtD
Oxprenolol—Hypotension—Felbamate—epilepsy syndrome	0.000296	0.00183	CcSEcCtD
Oxprenolol—Arthralgia—Carbamazepine—epilepsy syndrome	0.000295	0.00182	CcSEcCtD
Oxprenolol—Nausea—Phenobarbital—epilepsy syndrome	0.000293	0.00181	CcSEcCtD
Oxprenolol—Dyspepsia—Vigabatrin—epilepsy syndrome	0.000292	0.00181	CcSEcCtD
Oxprenolol—Thrombocytopenia—Clonazepam—epilepsy syndrome	0.000292	0.00181	CcSEcCtD
Oxprenolol—Dizziness—Clobazam—epilepsy syndrome	0.000292	0.0018	CcSEcCtD
Oxprenolol—Thrombocytopenia—Phenytoin—epilepsy syndrome	0.00029	0.00179	CcSEcCtD
Oxprenolol—Hypotension—Zonisamide—epilepsy syndrome	0.000289	0.00179	CcSEcCtD
Oxprenolol—Abdominal pain—Propofol—epilepsy syndrome	0.000289	0.00178	CcSEcCtD
Oxprenolol—Thrombocytopenia—Oxcarbazepine—epilepsy syndrome	0.000289	0.00178	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Felbamate—epilepsy syndrome	0.000288	0.00178	CcSEcCtD
Oxprenolol—Dyspepsia—Diazepam—epilepsy syndrome	0.000288	0.00178	CcSEcCtD
Oxprenolol—Nausea—Rufinamide—epilepsy syndrome	0.000288	0.00178	CcSEcCtD
Oxprenolol—Hyperhidrosis—Phenytoin—epilepsy syndrome	0.000286	0.00177	CcSEcCtD
Oxprenolol—Fatigue—Vigabatrin—epilepsy syndrome	0.000286	0.00177	CcSEcCtD
Oxprenolol—Insomnia—Felbamate—epilepsy syndrome	0.000286	0.00177	CcSEcCtD
Oxprenolol—Arthralgia—Lamotrigine—epilepsy syndrome	0.000285	0.00176	CcSEcCtD
Oxprenolol—Hyperhidrosis—Oxcarbazepine—epilepsy syndrome	0.000285	0.00176	CcSEcCtD
Oxprenolol—Headache—Lacosamide—epilepsy syndrome	0.000285	0.00176	CcSEcCtD
Oxprenolol—Asthenia—Acetazolamide—epilepsy syndrome	0.000282	0.00174	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Zonisamide—epilepsy syndrome	0.000282	0.00174	CcSEcCtD
Oxprenolol—Fatigue—Diazepam—epilepsy syndrome	0.000282	0.00174	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Topiramate—epilepsy syndrome	0.000282	0.00174	CcSEcCtD
Oxprenolol—Bradycardia—Pregabalin—epilepsy syndrome	0.000281	0.00174	CcSEcCtD
Oxprenolol—Insomnia—Zonisamide—epilepsy syndrome	0.00028	0.00173	CcSEcCtD
Oxprenolol—Abdominal pain—Levetiracetam—epilepsy syndrome	0.000279	0.00172	CcSEcCtD
Oxprenolol—Hypotension—Clonazepam—epilepsy syndrome	0.000279	0.00172	CcSEcCtD
Oxprenolol—Dyspepsia—Felbamate—epilepsy syndrome	0.000278	0.00172	CcSEcCtD
Oxprenolol—Thrombocytopenia—Carbamazepine—epilepsy syndrome	0.000277	0.00171	CcSEcCtD
Oxprenolol—Hypotension—Phenytoin—epilepsy syndrome	0.000277	0.00171	CcSEcCtD
Oxprenolol—Headache—Clobazam—epilepsy syndrome	0.000276	0.00171	CcSEcCtD
Oxprenolol—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000275	0.0017	CcSEcCtD
Oxprenolol—Hyperhidrosis—Carbamazepine—epilepsy syndrome	0.000273	0.00169	CcSEcCtD
Oxprenolol—Fatigue—Felbamate—epilepsy syndrome	0.000273	0.00169	CcSEcCtD
Oxprenolol—Dyspepsia—Zonisamide—epilepsy syndrome	0.000273	0.00168	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	0.000272	0.00168	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	0.00027	0.00167	CcSEcCtD
Oxprenolol—Nausea—Lacosamide—epilepsy syndrome	0.00027	0.00167	CcSEcCtD
Oxprenolol—Insomnia—Clonazepam—epilepsy syndrome	0.00027	0.00167	CcSEcCtD
Oxprenolol—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000269	0.00166	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.000269	0.00166	CcSEcCtD
Oxprenolol—Insomnia—Phenytoin—epilepsy syndrome	0.000268	0.00166	CcSEcCtD
Oxprenolol—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.000268	0.00166	CcSEcCtD
Oxprenolol—Fatigue—Zonisamide—epilepsy syndrome	0.000267	0.00165	CcSEcCtD
Oxprenolol—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000267	0.00165	CcSEcCtD
Oxprenolol—Hypotension—Carbamazepine—epilepsy syndrome	0.000264	0.00163	CcSEcCtD
Oxprenolol—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.000264	0.00163	CcSEcCtD
Oxprenolol—Hypersensitivity—Midazolam—epilepsy syndrome	0.000263	0.00163	CcSEcCtD
Oxprenolol—Dyspepsia—Clonazepam—epilepsy syndrome	0.000263	0.00162	CcSEcCtD
Oxprenolol—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000262	0.00162	CcSEcCtD
Oxprenolol—Nausea—Clobazam—epilepsy syndrome	0.000262	0.00162	CcSEcCtD
Oxprenolol—Asthenia—Propofol—epilepsy syndrome	0.000262	0.00162	CcSEcCtD
Oxprenolol—Dyspepsia—Phenytoin—epilepsy syndrome	0.000261	0.00161	CcSEcCtD
Oxprenolol—Dizziness—Acetazolamide—epilepsy syndrome	0.00026	0.00161	CcSEcCtD
Oxprenolol—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.00026	0.00161	CcSEcCtD
Oxprenolol—Sweating increased—Topiramate—epilepsy syndrome	0.00026	0.0016	CcSEcCtD
Oxprenolol—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.000259	0.0016	CcSEcCtD
Oxprenolol—Pruritus—Propofol—epilepsy syndrome	0.000258	0.0016	CcSEcCtD
Oxprenolol—Abdominal pain—Diazepam—epilepsy syndrome	0.000258	0.0016	CcSEcCtD
Oxprenolol—Bradycardia—Gabapentin—epilepsy syndrome	0.000258	0.0016	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000258	0.00159	CcSEcCtD
Oxprenolol—Fatigue—Clonazepam—epilepsy syndrome	0.000257	0.00159	CcSEcCtD
Oxprenolol—Asthenia—Midazolam—epilepsy syndrome	0.000256	0.00158	CcSEcCtD
Oxprenolol—Insomnia—Carbamazepine—epilepsy syndrome	0.000256	0.00158	CcSEcCtD
Oxprenolol—Fatigue—Phenytoin—epilepsy syndrome	0.000256	0.00158	CcSEcCtD
Oxprenolol—Metoprolol—CYP2C19—epilepsy syndrome	0.000255	0.111	CrCbGaD
Oxprenolol—Fatigue—Oxcarbazepine—epilepsy syndrome	0.000254	0.00157	CcSEcCtD
Oxprenolol—Asthenia—Levetiracetam—epilepsy syndrome	0.000253	0.00157	CcSEcCtD
Oxprenolol—Pruritus—Midazolam—epilepsy syndrome	0.000253	0.00156	CcSEcCtD
Oxprenolol—Abdominal pain—Felbamate—epilepsy syndrome	0.00025	0.00155	CcSEcCtD
Oxprenolol—Diarrhoea—Propofol—epilepsy syndrome	0.00025	0.00154	CcSEcCtD
Oxprenolol—Pruritus—Levetiracetam—epilepsy syndrome	0.00025	0.00154	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000249	0.00154	CcSEcCtD
Oxprenolol—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000249	0.00154	CcSEcCtD
Oxprenolol—Insomnia—Lamotrigine—epilepsy syndrome	0.000247	0.00153	CcSEcCtD
Oxprenolol—Headache—Acetazolamide—epilepsy syndrome	0.000246	0.00152	CcSEcCtD
Oxprenolol—Betaxolol—CYP2D6—epilepsy syndrome	0.000245	0.107	CrCbGaD
Oxprenolol—Abdominal pain—Zonisamide—epilepsy syndrome	0.000245	0.00151	CcSEcCtD
Oxprenolol—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000245	0.00151	CcSEcCtD
Oxprenolol—Asthenia—Fosphenytoin—epilepsy syndrome	0.000244	0.00151	CcSEcCtD
Oxprenolol—Fatigue—Carbamazepine—epilepsy syndrome	0.000244	0.00151	CcSEcCtD
Oxprenolol—Dizziness—Propofol—epilepsy syndrome	0.000241	0.00149	CcSEcCtD
Oxprenolol—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000241	0.00149	CcSEcCtD
Oxprenolol—Pruritus—Fosphenytoin—epilepsy syndrome	0.000241	0.00149	CcSEcCtD
Oxprenolol—Hypersensitivity—Diazepam—epilepsy syndrome	0.000241	0.00149	CcSEcCtD
Oxprenolol—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000241	0.00149	CcSEcCtD
Oxprenolol—Asthenia—Vigabatrin—epilepsy syndrome	0.000238	0.00147	CcSEcCtD
Oxprenolol—Bisoprolol—CYP2D6—epilepsy syndrome	0.000237	0.103	CrCbGaD
Oxprenolol—Dizziness—Midazolam—epilepsy syndrome	0.000236	0.00146	CcSEcCtD
Oxprenolol—Abdominal pain—Clonazepam—epilepsy syndrome	0.000236	0.00146	CcSEcCtD
Oxprenolol—Fatigue—Lamotrigine—epilepsy syndrome	0.000236	0.00146	CcSEcCtD
Oxprenolol—Palpitations—Valproic Acid—epilepsy syndrome	0.000235	0.00145	CcSEcCtD
Oxprenolol—Pruritus—Vigabatrin—epilepsy syndrome	0.000235	0.00145	CcSEcCtD
Oxprenolol—Asthenia—Diazepam—epilepsy syndrome	0.000234	0.00145	CcSEcCtD
Oxprenolol—Nausea—Acetazolamide—epilepsy syndrome	0.000234	0.00144	CcSEcCtD
Oxprenolol—Dizziness—Levetiracetam—epilepsy syndrome	0.000233	0.00144	CcSEcCtD
Oxprenolol—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000233	0.00144	CcSEcCtD
Oxprenolol—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000233	0.00144	CcSEcCtD
Oxprenolol—Pruritus—Diazepam—epilepsy syndrome	0.000231	0.00143	CcSEcCtD
Oxprenolol—Headache—Propofol—epilepsy syndrome	0.000229	0.00141	CcSEcCtD
Oxprenolol—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000228	0.00141	CcSEcCtD
Oxprenolol—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000227	0.0014	CcSEcCtD
Oxprenolol—Asthenia—Felbamate—epilepsy syndrome	0.000227	0.0014	CcSEcCtD
Oxprenolol—Arthralgia—Valproic Acid—epilepsy syndrome	0.000227	0.0014	CcSEcCtD
Oxprenolol—Dizziness—Fosphenytoin—epilepsy syndrome	0.000225	0.00139	CcSEcCtD
Oxprenolol—Acebutolol—CYP2D6—epilepsy syndrome	0.000224	0.0979	CrCbGaD
Oxprenolol—Headache—Midazolam—epilepsy syndrome	0.000224	0.00138	CcSEcCtD
Oxprenolol—Pruritus—Felbamate—epilepsy syndrome	0.000224	0.00138	CcSEcCtD
Oxprenolol—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000224	0.00138	CcSEcCtD
Oxprenolol—Diarrhoea—Diazepam—epilepsy syndrome	0.000224	0.00138	CcSEcCtD
Oxprenolol—Asthenia—Zonisamide—epilepsy syndrome	0.000222	0.00137	CcSEcCtD
Oxprenolol—Headache—Levetiracetam—epilepsy syndrome	0.000221	0.00137	CcSEcCtD
Oxprenolol—Hypersensitivity—Clonazepam—epilepsy syndrome	0.00022	0.00136	CcSEcCtD
Oxprenolol—Dizziness—Vigabatrin—epilepsy syndrome	0.000219	0.00136	CcSEcCtD
Oxprenolol—Pruritus—Zonisamide—epilepsy syndrome	0.000219	0.00135	CcSEcCtD
Oxprenolol—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000218	0.00135	CcSEcCtD
Oxprenolol—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000217	0.00134	CcSEcCtD
Oxprenolol—Bradycardia—Topiramate—epilepsy syndrome	0.000217	0.00134	CcSEcCtD
Oxprenolol—Nausea—Propofol—epilepsy syndrome	0.000217	0.00134	CcSEcCtD
Oxprenolol—Diarrhoea—Felbamate—epilepsy syndrome	0.000216	0.00134	CcSEcCtD
Oxprenolol—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000216	0.00134	CcSEcCtD
Oxprenolol—Dizziness—Diazepam—epilepsy syndrome	0.000216	0.00134	CcSEcCtD
Oxprenolol—Asthenia—Clonazepam—epilepsy syndrome	0.000214	0.00132	CcSEcCtD
Oxprenolol—Headache—Fosphenytoin—epilepsy syndrome	0.000213	0.00132	CcSEcCtD
Oxprenolol—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000213	0.00132	CcSEcCtD
Oxprenolol—Palpitations—Pregabalin—epilepsy syndrome	0.000213	0.00131	CcSEcCtD
Oxprenolol—Asthenia—Phenytoin—epilepsy syndrome	0.000213	0.00131	CcSEcCtD
Oxprenolol—Nausea—Midazolam—epilepsy syndrome	0.000212	0.00131	CcSEcCtD
Oxprenolol—Diarrhoea—Zonisamide—epilepsy syndrome	0.000212	0.00131	CcSEcCtD
Oxprenolol—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000212	0.00131	CcSEcCtD
Oxprenolol—Pruritus—Clonazepam—epilepsy syndrome	0.000211	0.00131	CcSEcCtD
Oxprenolol—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.00021	0.0013	CcSEcCtD
Oxprenolol—Pruritus—Phenytoin—epilepsy syndrome	0.00021	0.0013	CcSEcCtD
Oxprenolol—Nausea—Levetiracetam—epilepsy syndrome	0.00021	0.0013	CcSEcCtD
Oxprenolol—Dizziness—Felbamate—epilepsy syndrome	0.000209	0.00129	CcSEcCtD
Oxprenolol—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000209	0.00129	CcSEcCtD
Oxprenolol—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000208	0.00129	CcSEcCtD
Oxprenolol—Headache—Vigabatrin—epilepsy syndrome	0.000208	0.00129	CcSEcCtD
Oxprenolol—Arthralgia—Pregabalin—epilepsy syndrome	0.000205	0.00127	CcSEcCtD
Oxprenolol—Dizziness—Zonisamide—epilepsy syndrome	0.000205	0.00127	CcSEcCtD
Oxprenolol—Headache—Diazepam—epilepsy syndrome	0.000205	0.00127	CcSEcCtD
Oxprenolol—Diarrhoea—Clonazepam—epilepsy syndrome	0.000204	0.00126	CcSEcCtD
Oxprenolol—Alprenolol—CYP2D6—epilepsy syndrome	0.000203	0.0889	CrCbGaD
Oxprenolol—Hypotension—Valproic Acid—epilepsy syndrome	0.000203	0.00126	CcSEcCtD
Oxprenolol—Asthenia—Carbamazepine—epilepsy syndrome	0.000203	0.00125	CcSEcCtD
Oxprenolol—Diarrhoea—Phenytoin—epilepsy syndrome	0.000203	0.00125	CcSEcCtD
Oxprenolol—Nausea—Fosphenytoin—epilepsy syndrome	0.000202	0.00125	CcSEcCtD
Oxprenolol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000202	0.00125	CcSEcCtD
Oxprenolol—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000201	0.00125	CcSEcCtD
Oxprenolol—Pruritus—Carbamazepine—epilepsy syndrome	0.0002	0.00124	CcSEcCtD
Oxprenolol—Headache—Felbamate—epilepsy syndrome	0.000198	0.00123	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000198	0.00122	CcSEcCtD
Oxprenolol—Dizziness—Clonazepam—epilepsy syndrome	0.000197	0.00122	CcSEcCtD
Oxprenolol—Nausea—Vigabatrin—epilepsy syndrome	0.000197	0.00122	CcSEcCtD
Oxprenolol—Insomnia—Valproic Acid—epilepsy syndrome	0.000196	0.00121	CcSEcCtD
Oxprenolol—Asthenia—Lamotrigine—epilepsy syndrome	0.000196	0.00121	CcSEcCtD
Oxprenolol—Dizziness—Phenytoin—epilepsy syndrome	0.000196	0.00121	CcSEcCtD
Oxprenolol—Palpitations—Gabapentin—epilepsy syndrome	0.000195	0.00121	CcSEcCtD
Oxprenolol—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000195	0.00121	CcSEcCtD
Oxprenolol—Nausea—Diazepam—epilepsy syndrome	0.000194	0.0012	CcSEcCtD
Oxprenolol—Headache—Zonisamide—epilepsy syndrome	0.000194	0.0012	CcSEcCtD
Oxprenolol—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000194	0.0012	CcSEcCtD
Oxprenolol—Pruritus—Lamotrigine—epilepsy syndrome	0.000193	0.0012	CcSEcCtD
Oxprenolol—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000192	0.00119	CcSEcCtD
Oxprenolol—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000191	0.00118	CcSEcCtD
Oxprenolol—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.00019	0.00117	CcSEcCtD
Oxprenolol—Metoprolol—CYP2D6—epilepsy syndrome	0.000189	0.0826	CrCbGaD
Oxprenolol—Arthralgia—Gabapentin—epilepsy syndrome	0.000188	0.00116	CcSEcCtD
Oxprenolol—Nausea—Felbamate—epilepsy syndrome	0.000188	0.00116	CcSEcCtD
Oxprenolol—Fatigue—Valproic Acid—epilepsy syndrome	0.000187	0.00116	CcSEcCtD
Oxprenolol—Dizziness—Carbamazepine—epilepsy syndrome	0.000187	0.00116	CcSEcCtD
Oxprenolol—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000187	0.00116	CcSEcCtD
Oxprenolol—Headache—Clonazepam—epilepsy syndrome	0.000187	0.00116	CcSEcCtD
Oxprenolol—Headache—Phenytoin—epilepsy syndrome	0.000186	0.00115	CcSEcCtD
Oxprenolol—Headache—Oxcarbazepine—epilepsy syndrome	0.000185	0.00114	CcSEcCtD
Oxprenolol—Nausea—Zonisamide—epilepsy syndrome	0.000184	0.00114	CcSEcCtD
Oxprenolol—Hypotension—Pregabalin—epilepsy syndrome	0.000184	0.00113	CcSEcCtD
Oxprenolol—Dizziness—Lamotrigine—epilepsy syndrome	0.000181	0.00112	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000179	0.00111	CcSEcCtD
Oxprenolol—Insomnia—Pregabalin—epilepsy syndrome	0.000178	0.0011	CcSEcCtD
Oxprenolol—Nausea—Clonazepam—epilepsy syndrome	0.000177	0.0011	CcSEcCtD
Oxprenolol—Headache—Carbamazepine—epilepsy syndrome	0.000177	0.0011	CcSEcCtD
Oxprenolol—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000176	0.00109	CcSEcCtD
Oxprenolol—Nausea—Phenytoin—epilepsy syndrome	0.000176	0.00109	CcSEcCtD
Oxprenolol—Nausea—Oxcarbazepine—epilepsy syndrome	0.000175	0.00108	CcSEcCtD
Oxprenolol—Pindolol—CYP2D6—epilepsy syndrome	0.000175	0.0765	CrCbGaD
Oxprenolol—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000174	0.00108	CcSEcCtD
Oxprenolol—Atenolol—ABCB1—epilepsy syndrome	0.000173	0.0757	CrCbGaD
Oxprenolol—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000172	0.00106	CcSEcCtD
Oxprenolol—Headache—Lamotrigine—epilepsy syndrome	0.000171	0.00106	CcSEcCtD
Oxprenolol—Fatigue—Pregabalin—epilepsy syndrome	0.000169	0.00105	CcSEcCtD
Oxprenolol—Hypotension—Gabapentin—epilepsy syndrome	0.000168	0.00104	CcSEcCtD
Oxprenolol—Nausea—Carbamazepine—epilepsy syndrome	0.000168	0.00104	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000164	0.00101	CcSEcCtD
Oxprenolol—Palpitations—Topiramate—epilepsy syndrome	0.000164	0.00101	CcSEcCtD
Oxprenolol—Insomnia—Gabapentin—epilepsy syndrome	0.000163	0.00101	CcSEcCtD
Oxprenolol—Nausea—Lamotrigine—epilepsy syndrome	0.000162	0.001	CcSEcCtD
Oxprenolol—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.00016	0.00099	CcSEcCtD
Oxprenolol—Acebutolol—ABCB1—epilepsy syndrome	0.00016	0.0699	CrCbGaD
Oxprenolol—Dyspepsia—Gabapentin—epilepsy syndrome	0.000159	0.00098	CcSEcCtD
Oxprenolol—Arthralgia—Topiramate—epilepsy syndrome	0.000158	0.000977	CcSEcCtD
Oxprenolol—Asthenia—Valproic Acid—epilepsy syndrome	0.000156	0.000964	CcSEcCtD
Oxprenolol—Fatigue—Gabapentin—epilepsy syndrome	0.000155	0.00096	CcSEcCtD
Oxprenolol—Abdominal pain—Pregabalin—epilepsy syndrome	0.000155	0.00096	CcSEcCtD
Oxprenolol—Pruritus—Valproic Acid—epilepsy syndrome	0.000154	0.00095	CcSEcCtD
Oxprenolol—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000149	0.000919	CcSEcCtD
Oxprenolol—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000148	0.000917	CcSEcCtD
Oxprenolol—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000146	0.000906	CcSEcCtD
Oxprenolol—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000145	0.000895	CcSEcCtD
Oxprenolol—Dizziness—Valproic Acid—epilepsy syndrome	0.000144	0.000888	CcSEcCtD
Oxprenolol—Abdominal pain—Gabapentin—epilepsy syndrome	0.000142	0.00088	CcSEcCtD
Oxprenolol—Hypotension—Topiramate—epilepsy syndrome	0.000142	0.000875	CcSEcCtD
Oxprenolol—Asthenia—Pregabalin—epilepsy syndrome	0.000141	0.000871	CcSEcCtD
Oxprenolol—Pruritus—Pregabalin—epilepsy syndrome	0.000139	0.000859	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000138	0.000854	CcSEcCtD
Oxprenolol—Insomnia—Topiramate—epilepsy syndrome	0.000137	0.000847	CcSEcCtD
Oxprenolol—Headache—Valproic Acid—epilepsy syndrome	0.000136	0.000842	CcSEcCtD
Oxprenolol—Metoprolol—ABCB1—epilepsy syndrome	0.000135	0.059	CrCbGaD
Oxprenolol—Diarrhoea—Pregabalin—epilepsy syndrome	0.000134	0.000831	CcSEcCtD
Oxprenolol—Dyspepsia—Topiramate—epilepsy syndrome	0.000133	0.000825	CcSEcCtD
Oxprenolol—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000133	0.00082	CcSEcCtD
Oxprenolol—Fatigue—Topiramate—epilepsy syndrome	0.000131	0.000808	CcSEcCtD
Oxprenolol—Dizziness—Pregabalin—epilepsy syndrome	0.00013	0.000803	CcSEcCtD
Oxprenolol—Asthenia—Gabapentin—epilepsy syndrome	0.000129	0.000799	CcSEcCtD
Oxprenolol—Nausea—Valproic Acid—epilepsy syndrome	0.000129	0.000798	CcSEcCtD
Oxprenolol—Propranolol—CYP2C19—epilepsy syndrome	0.000129	0.0563	CrCbGaD
Oxprenolol—Pruritus—Gabapentin—epilepsy syndrome	0.000127	0.000788	CcSEcCtD
Oxprenolol—Diarrhoea—Gabapentin—epilepsy syndrome	0.000123	0.000762	CcSEcCtD
Oxprenolol—Headache—Pregabalin—epilepsy syndrome	0.000123	0.000761	CcSEcCtD
Oxprenolol—Abdominal pain—Topiramate—epilepsy syndrome	0.00012	0.000741	CcSEcCtD
Oxprenolol—Dizziness—Gabapentin—epilepsy syndrome	0.000119	0.000736	CcSEcCtD
Oxprenolol—Nausea—Pregabalin—epilepsy syndrome	0.000117	0.000721	CcSEcCtD
Oxprenolol—Headache—Gabapentin—epilepsy syndrome	0.000113	0.000698	CcSEcCtD
Oxprenolol—Hypersensitivity—Topiramate—epilepsy syndrome	0.000112	0.00069	CcSEcCtD
Oxprenolol—Asthenia—Topiramate—epilepsy syndrome	0.000109	0.000672	CcSEcCtD
Oxprenolol—Pruritus—Topiramate—epilepsy syndrome	0.000107	0.000663	CcSEcCtD
Oxprenolol—Nausea—Gabapentin—epilepsy syndrome	0.000107	0.000661	CcSEcCtD
Oxprenolol—Diarrhoea—Topiramate—epilepsy syndrome	0.000104	0.000641	CcSEcCtD
Oxprenolol—Dizziness—Topiramate—epilepsy syndrome	0.0001	0.00062	CcSEcCtD
Oxprenolol—Propranolol—CYP2D6—epilepsy syndrome	9.55e-05	0.0417	CrCbGaD
Oxprenolol—Headache—Topiramate—epilepsy syndrome	9.49e-05	0.000587	CcSEcCtD
Oxprenolol—Nausea—Topiramate—epilepsy syndrome	9e-05	0.000556	CcSEcCtD
Oxprenolol—Propranolol—ABCB1—epilepsy syndrome	6.82e-05	0.0298	CrCbGaD
Oxprenolol—ADRB2—Signaling by GPCR—CXCL12—epilepsy syndrome	2.03e-05	0.000245	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—BDKRB2—epilepsy syndrome	2.03e-05	0.000245	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PLCB1—epilepsy syndrome	2.03e-05	0.000245	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CHRM1—epilepsy syndrome	2.03e-05	0.000244	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PDYN—epilepsy syndrome	2.03e-05	0.000244	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GRM1—epilepsy syndrome	2.03e-05	0.000244	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCR7—epilepsy syndrome	2.03e-05	0.000244	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	2.02e-05	0.000243	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PFKL—epilepsy syndrome	2.02e-05	0.000243	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	2.02e-05	0.000243	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	2.02e-05	0.000243	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	2.02e-05	0.000243	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CNR1—epilepsy syndrome	2e-05	0.000241	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HTR7—epilepsy syndrome	1.99e-05	0.00024	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PLCB1—epilepsy syndrome	1.99e-05	0.00024	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CHRM1—epilepsy syndrome	1.98e-05	0.000239	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GRM1—epilepsy syndrome	1.98e-05	0.000239	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCR7—epilepsy syndrome	1.98e-05	0.000239	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PDYN—epilepsy syndrome	1.98e-05	0.000239	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HTR7—epilepsy syndrome	1.95e-05	0.000235	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HBEGF—epilepsy syndrome	1.93e-05	0.000233	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CDC42—epilepsy syndrome	1.91e-05	0.00023	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GAL—epilepsy syndrome	1.91e-05	0.00023	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GFAP—epilepsy syndrome	1.91e-05	0.00023	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AKT3—epilepsy syndrome	1.9e-05	0.000229	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HBEGF—epilepsy syndrome	1.89e-05	0.000228	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GRM5—epilepsy syndrome	1.89e-05	0.000227	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CASP2—epilepsy syndrome	1.89e-05	0.000227	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CHRM3—epilepsy syndrome	1.89e-05	0.000227	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CDC42—epilepsy syndrome	1.87e-05	0.000225	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GAL—epilepsy syndrome	1.86e-05	0.000225	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GFAP—epilepsy syndrome	1.86e-05	0.000225	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AKT3—epilepsy syndrome	1.86e-05	0.000224	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AVP—epilepsy syndrome	1.85e-05	0.000223	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CHRM3—epilepsy syndrome	1.84e-05	0.000222	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GRM5—epilepsy syndrome	1.84e-05	0.000222	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CASP2—epilepsy syndrome	1.84e-05	0.000222	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ATIC—epilepsy syndrome	1.84e-05	0.000222	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NEU1—epilepsy syndrome	1.84e-05	0.000222	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—UPB1—epilepsy syndrome	1.84e-05	0.000222	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.81e-05	0.000218	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AVP—epilepsy syndrome	1.81e-05	0.000218	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	1.77e-05	0.000214	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.77e-05	0.000214	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CHRM2—epilepsy syndrome	1.77e-05	0.000214	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.77e-05	0.000214	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CX3CR1—epilepsy syndrome	1.77e-05	0.000213	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ABCG2—epilepsy syndrome	1.75e-05	0.000211	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—BDKRB1—epilepsy syndrome	1.73e-05	0.000209	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CHRM2—epilepsy syndrome	1.73e-05	0.000209	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CX3CL1—epilepsy syndrome	1.73e-05	0.000209	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CDC42—epilepsy syndrome	1.73e-05	0.000209	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GABBR1—epilepsy syndrome	1.72e-05	0.000208	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	1.71e-05	0.000207	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GBE1—epilepsy syndrome	1.71e-05	0.000207	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP2C19—epilepsy syndrome	1.7e-05	0.000205	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CDC42—epilepsy syndrome	1.69e-05	0.000204	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP11A1—epilepsy syndrome	1.69e-05	0.000204	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GABBR1—epilepsy syndrome	1.69e-05	0.000203	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AVP—epilepsy syndrome	1.68e-05	0.000202	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HRH3—epilepsy syndrome	1.65e-05	0.000199	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AVP—epilepsy syndrome	1.64e-05	0.000198	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—OPRM1—epilepsy syndrome	1.63e-05	0.000196	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HRH3—epilepsy syndrome	1.62e-05	0.000195	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	1.61e-05	0.000194	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—OPRM1—epilepsy syndrome	1.59e-05	0.000192	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.57e-05	0.000189	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	1.57e-05	0.000189	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCR3—epilepsy syndrome	1.54e-05	0.000185	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.54e-05	0.000185	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.54e-05	0.000185	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP2D6—epilepsy syndrome	1.53e-05	0.000184	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NT5E—epilepsy syndrome	1.53e-05	0.000184	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALAD—epilepsy syndrome	1.53e-05	0.000184	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCR3—epilepsy syndrome	1.5e-05	0.000181	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.5e-05	0.000181	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NPY—epilepsy syndrome	1.5e-05	0.000181	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.5e-05	0.000181	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NPY—epilepsy syndrome	1.46e-05	0.000177	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.46e-05	0.000177	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.46e-05	0.000176	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AGT—epilepsy syndrome	1.46e-05	0.000176	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	1.46e-05	0.000176	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	1.46e-05	0.000176	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ADRA2A—epilepsy syndrome	1.46e-05	0.000175	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—BCHE—epilepsy syndrome	1.45e-05	0.000175	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HSPB1—epilepsy syndrome	1.44e-05	0.000174	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—OXT—epilepsy syndrome	1.44e-05	0.000174	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CXCL2—epilepsy syndrome	1.44e-05	0.000174	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CRH—epilepsy syndrome	1.44e-05	0.000174	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCL3—epilepsy syndrome	1.44e-05	0.000174	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	1.43e-05	0.000172	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AGT—epilepsy syndrome	1.43e-05	0.000172	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CCR5—epilepsy syndrome	1.43e-05	0.000172	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCL3—epilepsy syndrome	1.41e-05	0.00017	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HSPB1—epilepsy syndrome	1.41e-05	0.00017	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CRH—epilepsy syndrome	1.41e-05	0.00017	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—OXT—epilepsy syndrome	1.41e-05	0.00017	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CXCL2—epilepsy syndrome	1.41e-05	0.00017	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ADSL—epilepsy syndrome	1.4e-05	0.000168	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.39e-05	0.000168	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CCR5—epilepsy syndrome	1.39e-05	0.000168	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—SLC2A1—epilepsy syndrome	1.38e-05	0.000167	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GLUL—epilepsy syndrome	1.37e-05	0.000165	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PLCB1—epilepsy syndrome	1.37e-05	0.000165	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.36e-05	0.000165	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—TH—epilepsy syndrome	1.36e-05	0.000164	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.35e-05	0.000162	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	1.34e-05	0.000162	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTK2B—epilepsy syndrome	1.34e-05	0.000162	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TSC1—epilepsy syndrome	1.34e-05	0.000162	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AGT—epilepsy syndrome	1.32e-05	0.00016	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.32e-05	0.000159	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTK2B—epilepsy syndrome	1.31e-05	0.000158	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TSC1—epilepsy syndrome	1.31e-05	0.000158	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SST—epilepsy syndrome	1.31e-05	0.000158	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCR2—epilepsy syndrome	1.31e-05	0.000158	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NTRK2—epilepsy syndrome	1.31e-05	0.000158	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—DUSP6—epilepsy syndrome	1.3e-05	0.000156	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AGT—epilepsy syndrome	1.29e-05	0.000156	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.28e-05	0.000154	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	1.28e-05	0.000154	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SST—epilepsy syndrome	1.28e-05	0.000154	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	1.28e-05	0.000154	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	1.27e-05	0.000154	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	1.27e-05	0.000153	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	1.26e-05	0.000152	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.25e-05	0.000151	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	1.25e-05	0.00015	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.23e-05	0.000148	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	1.23e-05	0.000148	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	1.23e-05	0.000148	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.22e-05	0.000147	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AQP1—epilepsy syndrome	1.22e-05	0.000147	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.22e-05	0.000147	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	1.21e-05	0.000145	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	1.21e-05	0.000145	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	1.2e-05	0.000145	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.2e-05	0.000145	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	1.2e-05	0.000145	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	1.2e-05	0.000145	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.2e-05	0.000144	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.19e-05	0.000144	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	1.18e-05	0.000142	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	1.18e-05	0.000142	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	1.18e-05	0.000142	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	1.18e-05	0.000142	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	1.15e-05	0.000139	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	1.14e-05	0.000138	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—HMOX1—epilepsy syndrome	1.14e-05	0.000137	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CAT—epilepsy syndrome	1.12e-05	0.000135	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	1.12e-05	0.000135	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	1.12e-05	0.000135	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	1.11e-05	0.000134	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.1e-05	0.000133	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.1e-05	0.000133	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	1.1e-05	0.000132	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	1.1e-05	0.000132	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ABCB1—epilepsy syndrome	1.09e-05	0.000132	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	1.09e-05	0.000131	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	1.09e-05	0.000131	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	1.07e-05	0.000129	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	1.07e-05	0.000129	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	1.04e-05	0.000125	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	1.03e-05	0.000124	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	1.02e-05	0.000123	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GPX1—epilepsy syndrome	1.01e-05	0.000122	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	1.01e-05	0.000122	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	1e-05	0.000121	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	1e-05	0.000121	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	9.9e-06	0.000119	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	9.69e-06	0.000117	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	9.36e-06	0.000113	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	9.16e-06	0.00011	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	9.11e-06	0.00011	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	9.07e-06	0.000109	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	9.06e-06	0.000109	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	9e-06	0.000109	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	8.91e-06	0.000107	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AGT—epilepsy syndrome	8.9e-06	0.000107	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	8.88e-06	0.000107	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	8.86e-06	0.000107	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	8.77e-06	0.000106	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	8.75e-06	0.000106	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	8.72e-06	0.000105	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOE—epilepsy syndrome	8.72e-06	0.000105	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	8.66e-06	0.000104	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	8.56e-06	0.000103	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	8.47e-06	0.000102	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	8.42e-06	0.000102	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	8.24e-06	9.93e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	8.24e-06	9.93e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	8.06e-06	9.72e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	7.83e-06	9.44e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	7.82e-06	9.43e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	7.66e-06	9.24e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	7.66e-06	9.23e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	7.65e-06	9.22e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	7.5e-06	9.05e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	7.49e-06	9.03e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	7.49e-06	9.03e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—POMC—epilepsy syndrome	7.49e-06	9.03e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—BCHE—epilepsy syndrome	7.46e-06	8.99e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	7.34e-06	8.85e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	7.22e-06	8.71e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	7.2e-06	8.67e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	7.12e-06	8.58e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	7.07e-06	8.52e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	7.04e-06	8.49e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	7.04e-06	8.49e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TH—epilepsy syndrome	7.01e-06	8.46e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ALB—epilepsy syndrome	6.83e-06	8.23e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	6.58e-06	7.93e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	6.44e-06	7.76e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	6.44e-06	7.76e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	6.3e-06	7.59e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	5.97e-06	7.2e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	5.85e-06	7.06e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	5.82e-06	7.02e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CAT—epilepsy syndrome	5.78e-06	6.96e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	5.69e-06	6.86e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	5.62e-06	6.77e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	5.4e-06	6.51e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	5.3e-06	6.39e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	5.28e-06	6.37e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GPX1—epilepsy syndrome	5.22e-06	6.3e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	5.18e-06	6.25e-05	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.92e-06	5.93e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	4.87e-06	5.87e-05	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	4.81e-06	5.8e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	4.77e-06	5.75e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	4.73e-06	5.71e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	4.63e-06	5.58e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	4.6e-06	5.55e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AGT—epilepsy syndrome	4.58e-06	5.52e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	4.5e-06	5.43e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOE—epilepsy syndrome	4.49e-06	5.41e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	4.47e-06	5.38e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	4.37e-06	5.27e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	4.25e-06	5.12e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	4.15e-06	5.01e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	4.13e-06	4.98e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	4.04e-06	4.88e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—POMC—epilepsy syndrome	3.86e-06	4.65e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALB—epilepsy syndrome	3.52e-06	4.24e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	3.08e-06	3.71e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AKT1—epilepsy syndrome	3e-06	3.62e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	2.64e-06	3.18e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	2.58e-06	3.11e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.55e-06	1.86e-05	CbGpPWpGaD
